TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
27 hedge funds and large institutions have $2.9M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
27
Holding in Top 10
–
Calls
$11K
Puts
–
Top Buyers
| 1 | +$44.3K | |
| 2 | +$14K | |
| 3 | +$8K | |
| 4 |
Millennium Management
New York
|
+$2.74K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.06K |
Top Sellers
| 1 | -$79.1K | |
| 2 | -$37.8K | |
| 3 | -$34K | |
| 4 |
Jane Street
New York
|
-$32.1K |
| 5 |
Two Sigma Advisers
New York
|
-$19.5K |